These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 18164257

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
    Denk GU, Maitz S, Wimmer R, Rust C, Invernizzi P, Ferdinandusse S, Kulik W, Fuchsbichler A, Fickert P, Trauner M, Hofmann AF, Beuers U.
    Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
    [Abstract] [Full Text] [Related]

  • 4. The human transcription factor AP-1 is a mediator of bile acid-induced liver cell apoptosis.
    Bernt C, Vennegeerts T, Beuers U, Rust C.
    Biochem Biophys Res Commun; 2006 Feb 17; 340(3):800-6. PubMed ID: 16380075
    [Abstract] [Full Text] [Related]

  • 5. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.
    Beuers U, Bilzer M, Chittattu A, Kullak-Ublick GA, Keppler D, Paumgartner G, Dombrowski F.
    Hepatology; 2001 May 17; 33(5):1206-16. PubMed ID: 11343250
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.
    Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, Haisma HJ, Jansen PL, Moshage H.
    Hepatology; 2004 Jun 17; 39(6):1563-73. PubMed ID: 15185297
    [Abstract] [Full Text] [Related]

  • 8. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
    Alpini G, Baiocchi L, Glaser S, Ueno Y, Marzioni M, Francis H, Phinizy JL, Angelico M, Lesage G.
    Hepatology; 2002 May 17; 35(5):1041-52. PubMed ID: 11981754
    [Abstract] [Full Text] [Related]

  • 9. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.
    Castro RE, Amaral JD, Solá S, Kren BT, Steer CJ, Rodrigues CM.
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul 17; 293(1):G327-34. PubMed ID: 17431217
    [Abstract] [Full Text] [Related]

  • 10. [Effect of Tauroursodeoxycholic acid on cytochrome C-mediated apoptosis in HepG2 cells].
    Xie Q, Li GM, Zhou XQ, Liao D, Yu H, Guo Q.
    Zhonghua Gan Zang Bing Za Zhi; 2003 May 17; 11(5):298-301. PubMed ID: 12773247
    [Abstract] [Full Text] [Related]

  • 11. Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets.
    Beuers U, Denk GU, Soroka CJ, Wimmer R, Rust C, Paumgartner G, Boyer JL.
    J Biol Chem; 2003 May 16; 278(20):17810-8. PubMed ID: 12626520
    [Abstract] [Full Text] [Related]

  • 12. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
    Perez MJ, Macias RI, Duran C, Monte MJ, Gonzalez-Buitrago JM, Marin JJ.
    J Hepatol; 2005 Aug 16; 43(2):324-32. PubMed ID: 15970352
    [Abstract] [Full Text] [Related]

  • 13. Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition.
    Wang L, Piguet AC, Schmidt K, Tordjmann T, Dufour JF.
    Hepatology; 2005 Jun 16; 41(6):1241-51. PubMed ID: 15861431
    [Abstract] [Full Text] [Related]

  • 14. Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease.
    Ramalho RM, Viana RJ, Low WC, Steer CJ, Rodrigues CM.
    Trends Mol Med; 2008 Feb 16; 14(2):54-62. PubMed ID: 18218342
    [Abstract] [Full Text] [Related]

  • 15. Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats.
    Colak A, Kelten B, Sağmanligil A, Akdemir O, Karaoğlan A, Sahan E, Celik O, Barut S.
    J Clin Neurosci; 2008 Jun 16; 15(6):665-71. PubMed ID: 18343118
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
    Azer SA, Canfield PJ, Stacey NH.
    J Gastroenterol Hepatol; 1995 Jun 16; 10(3):261-9. PubMed ID: 7548801
    [Abstract] [Full Text] [Related]

  • 19. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
    Paumgartner G, Beuers U.
    Hepatology; 2002 Sep 16; 36(3):525-31. PubMed ID: 12198643
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.